ANXA5 and malignant colon neoplasm: In HCT116 cells all five SL analogues increased the percentage of early (Annexin V+/PI-) and late (Annexin V+/PI+) apoptotic cells in a dose dependent manner (Figure 3A) and similar results were observed in two additional colon cancer cell lines, (SW480, HT29, Figure S2).